🔎 Trials Near Me

መነሻ › አኩት ሊምፎብላስቲክ ሊውኬሚያ

በአሜሪካ ለአኩት ሊምፎብላስቲክ ሊውኬሚያ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች

ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ 134 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በጣም ብዙ ጥናቶች ያሏቸው ከተሞች

በክልል

በቅርብ ጊዜ የተዘመኑ ጥናቶች

Official study text (English)

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT01853631

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06904066

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07572136

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07328503

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05442515

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

ተሳታዮችን በመፈለግ ላይደረጃ 2
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06514794

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06144606

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06398457

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
4 Weeks – 18 Years · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06308588

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06819475

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
30 Days · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04065399

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ0 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06173518

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06904482

Cord Blood Transplant in Adults With Blood Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ21 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05884333

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT03104491

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06408194

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07586618

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እስከ እድሜ 50 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT05322850

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT04881240

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07257419

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።